Swedencare (SECARE) Pre-close call summary
Event summary combining transcript, slides, and related documents.
Pre-close call summary
17 Jun, 2026Executive summary
Strong presence at Interzoo led to new market launches and increased brand exposure, with several negotiations for expansion underway in H2.
Capital market day and AGM held, with positive feedback and board changes including a new chairman and a Symrise representative.
Authorization for share buybacks granted, to be used when deemed prudent.
Trading performance and revenue trends
Double-digit organic growth expected for the quarter, with online channels in Europe and North America showing strong improvement.
NaturVet by Swedencare expanded online in Europe and launched on Amazon and UK shop, with retail rollout planned for H2.
Two business segments performing strongly, while Europe and North American production remain below desired pace.
U.S. supplements solid, but dermal liquids remain soft due to distributor merger and seasonality.
Profitability and margins
Gross margin expected to remain in the 58%-59% range, consistent with previous quarters.
EBITDA margin anticipated to improve year-on-year and be similar to Q1's 19.6%.
No significant inflationary pressures reported; cost structure stable.
Profitability pressure from Amazon and big box channels expected to ease in H2.
Latest events from Swedencare
- Double-digit growth and digital expansion drive global strategy and margin improvement.SECARE
CMD 202610 Jun 2026 - Double-digit organic growth and record gross margin highlight a strong start to 2026.SECARE
Q1 202623 Apr 2026 - Q4 organic growth was strong, but one-off costs pressured margins; recovery expected in 2026.SECARE
Q4 202510 Apr 2026 - Improved margins and strong sales drive a positive outlook as operational challenges ease.SECARE
Pre-close call20 Mar 2026 - Q2 revenue up 10% with margin gains, strong European growth, and strategic acquisitions.SECARE
Q2 20243 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Q1 2025 delivered 7% revenue growth, strong cash flow, and key acquisitions for future expansion.SECARE
Q1 202523 Dec 2025 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025